-
June 15, 2021 University of Calgary Creates Canada’s First Chair for Psychedelic ResearchCanada gets its first chair for psychedelic research thanks to private citizen funding to the...
-
June 14, 2021 80 to 100% of Amputees Experience Phantom Limb Syndrome. Psilocybin May Help.New research into psychedelics shows psilocybin may help amputees suffering from pain associated with phantom...
-
June 11, 2021 Do Psychedelics Hold the Key to Explaining Near-Death Experiences?New research into psychedelics shows it may help scientists better understand the phenomenon known as...
-
June 8, 2021 Cybin Launches First Clinical Trial to Treat Frontline Workers Experiencing COVID-Related Distress With PsychedelicsA new first-of-its-kind psychedelic study will treat frontline workers experiencing distress related to COVID with...
-
June 4, 2021 Biotech Firm PsyBio Therapeutics Is Producing Psilocybin From BacteriaPsyBio Therapeutics is harvesting the psychedelic compound psilocybin from a strain of bacteria instead of...
-
June 2, 2021 Cybin Taps First-of-Its-Kind Device to Study Psychedelic Effects of KetamineA new device may help Cybin better understand the psychedelic impact of the drug ketamine...
-
May 25, 2021 Research to Look at Psychedelics for Autism TreatmentNew research from Nova Mentis will explore the potential benefits of psychedelics in treating autism...
-
May 25, 2021 FDA Approves First-Ever MDMA Study for Therapist Volunteers to Better Treat PTSD PatientsThe FDA has approved a novel study allowing therapists who treat PTSD to take MDMA...
-
May 18, 2021 Algernon to Become the First Company in the World to Study DMT for Stroke PatientsAlgernon Pharmaceuticals has received FDA approval to study DMT for use in stroke patients to...
-
May 17, 2021 FDA Green-Lights Ketamine Study for Side Effects of Parkinson’s Disease TreatmentResearch into ketamine as a potential treatment for Parkinson's patients suffering from drug side effects...
